<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02907242</url>
  </required_header>
  <id_info>
    <org_study_id>RATIO37</org_study_id>
    <nct_id>NCT02907242</nct_id>
  </id_info>
  <brief_title>Revealed Versus Concealed Cerebroplacental Ratio</brief_title>
  <official_title>Revealed Versus Concealed Criteria for Placental Insufficiency in Unselected Obstetric Population in Late Pregnancy: a Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the role of an integrated strategy at selecting
      fetuses for delivery at term based on a combination of fetal biometry and cerebroplacental
      ratio (CPR) to reduce stillbirth rate and adverse perinatal outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, open-label randomized trial with groups in parallel. Singleton
      pregnancies are recruited after routine second trimester scan (19+0 to 22+6 weeks of
      gestation) and randomly allocated at that moment to revealed or concealed strategy. A routine
      scan will be booked at 36-37 weeks. For a reduction of the stillbirth rate of 3‰ (from 5‰ to
      2‰), assuming a type I error of 5% and aiming for a power of 80% a total of 11,582 subjects
      (5791 per arm) were projected. The participating centers sum up 12,000 deliveries a year. It
      is not possible to blind participants, obstetricians, or outcome assessors to the study
      group.

      General hypothesis: A proportion of fetuses with &quot;normal&quot; growth as per current standards
      have placental insufficiency and restriction of their growth potential. These fetuses exhibit
      biophysical changes expressed by abnormal cerebroplacental ratio. A combination of this
      marker with fetal biometry for the detection of fetuses affected by fetal growth restriction
      could identify a group of babies on which labor induction once term is reached may prevent
      the occurrence of adverse outcomes.

      Specific hypothesis

        -  The cerebroplacental ratio has predictive value in late pregnancy for placental
           insufficiency.

        -  The cerebroplacental ratio could improve the effectiveness of late pregnancy screening
           for the prediction placental insufficiency-related complications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stillbirth</measure>
    <time_frame>between 37 and 42 weeks of pregnancy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse perinatal outcome</measure>
    <time_frame>Up to 28 days after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal Growth Restriction Detection</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">11582</enrollment>
  <condition>Stillbirth</condition>
  <arm_group>
    <arm_group_label>Concealment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cerebroplacental ratio measurement at 37 weeks of pregnancy only taken into account if estimated fetal weight &lt;p10</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Revealment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cerebroplacental ratio measurement at 37weeks and labor induction in case of cerebroplacental ratio &lt;p5</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Revealment</intervention_name>
    <description>Cerebroplacental ratio revealment</description>
    <arm_group_label>Revealment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Viable singleton non-malformed fetus

          -  Available first-trimester US dating

          -  Maternal age at recruitment ≥18 years

          -  No adverse medical or obstetrical history at booking

          -  Capacity to give informed consent

        Exclusion Criteria:

          -  Abnormal karyotype

          -  Structural abnormalities

          -  Congenital infections
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduard Gratacos, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesc Figueras, PhD</last_name>
    <phone>0034932279946</phone>
    <email>ffiguera@clinic.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marta Rial, MD</last_name>
    <phone>0034932279946</phone>
    <email>mrial@clinic.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Santiago de Chile</name>
      <address>
        <city>Santiago de Chile</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Palacky University Hospital</name>
      <address>
        <city>Olomouc</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Lubusky, PhD</last_name>
      <email>marek@lubusky.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Querétaro</name>
      <address>
        <city>Querétaro</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rogelio Cruz, PhD</last_name>
      <email>cruz-martinezr@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Rial, MD</last_name>
      <phone>0034932279946</phone>
      <email>mrial@clinic.cat</email>
    </contact>
    <contact_backup>
      <last_name>Francesc Figueras, PhD</last_name>
      <phone>00342279946</phone>
      <email>ffiguera@clinic.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Eduard Gratacos, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopitaux Universitaires de Geneve</name>
      <address>
        <city>Geneve</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Begoña Martinez, PhD</last_name>
      <email>Begona.MartinezDeTejada@hcuge.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Mexico</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>September 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <last_update_submitted>September 15, 2016</last_update_submitted>
  <last_update_submitted_qc>September 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Francesc Figueras</investigator_full_name>
    <investigator_title>Obstetrics Department Head Hospital Clinic Barcelona</investigator_title>
  </responsible_party>
  <keyword>stillbirth</keyword>
  <keyword>cerebroplacental ratio</keyword>
  <keyword>fetal growth restriction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stillbirth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

